Results 211 to 220 of about 68,812 (293)

Comparative Analysis of the Immune Profiles of Women and Men With Hepatocellular Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Introduction Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major global health concern, with a higher incidence in men than in women. In the era of immunotherapy, understanding sex‐based immunological differences is crucial.
Zuzana Macek Jilkova   +8 more
wiley   +1 more source

Asymptomatic Medullary Thyroid Carcinoma With Isolated Carcinoembryonic Antigen Elevation in a Patient With Chronic Kidney Disease: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Medullary thyroid carcinoma (MTC) is rare and typically presents with a palpable nodule. We report a 64‐year‐old asymptomatic woman with chronic kidney disease (CKD) diagnosed with MTC after incidental procalcitonin elevation on routine labs, highlighting procalcitonin as an atypical clue and the need to distinguish tumor‐related from CKD ...
Orhan Altınyüzük   +3 more
wiley   +1 more source

The Role of CD56 as an Immunophenotypic Marker in the Clinical Course of Multiple Myeloma. [PDF]

open access: yesJ Clin Med
Karabekov A   +17 more
europepmc   +1 more source

Parallel processing of T cells and natural killer cells to enhance in vivo CAR T cell activity against blood and solid cancers

open access: yesClinical &Translational Immunology, Volume 15, Issue 9, 2026.
Abstract Objectives Despite their anti‐cancer properties, natural killer (NK) cells are discarded during CAR T cell manufacturing. NK cells display promising responses as a cell therapy, exhibiting remarkable safety at high doses. Moreover, NK cells have complementary cytokine profiles and distinct antigen‐recognition pathways to supplement CAR T cell ...
Lachlan J Dobson   +7 more
wiley   +1 more source

Cancer cell‐selective ectopic expression of CD20 as an antigen enables rituximab repurposing for solid tumour immunotherapy

open access: yesClinical and Translational Medicine, Volume 16, Issue 9, September 2026.
A recombinant AAV delivered tumour gene therapy. NF‐κB drives tumour‐selective antigen (e.g., CD20) expression. Ectopic CD20 enables rituximab repurposing to solid tumours. ADCC, ADCP, and CDC contribute to the antitumour activity. Abstract Background Despite the clinical success of cancer immunotherapies, their efficacy is often compromised by antigen‐
Ziyan Kong   +6 more
wiley   +1 more source

DinoFlow: Self‐supervised pretraining in flow cytometry enables accurate detection of common hematopathological disorders

open access: yesCytometry Part B: Clinical Cytometry, Volume 110, Issue 5, Page 347-358, September 2026.
Abstract Flow cytometry is an essential component of routine hematological lab testing. Many computational methods have been proposed for the analysis of flow cytometry data, but most have focused on supervised learning for just one or a few specific disorders.
Brendan O'Fallon   +4 more
wiley   +1 more source

Case Report: Clinical characteristics and outcomes in natural killer (NK)/T-cell lymphomas with cardiac involvement: a case series and literature review. [PDF]

open access: yesFront Cardiovasc Med
Robinson G   +9 more
europepmc   +1 more source

Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. [PDF]

open access: yesJ Immunother Cancer
Alashkar Alhamwe B   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy